The proposed bill seeks to strengthen privacy protections for health care information, particularly in the context of reproductive and gender-affirming health care. It introduces regulations that prevent the release of an individual's health care information in response to foreign subpoenas unless specific conditions, such as obtaining consent or a court order, are met. The bill mandates that covered entities notify individuals and providers about such requests and grants immunity from liability for those who refuse to disclose information under these new provisions. Additionally, it prohibits location tracking at reproductive and gender-affirming health care facilities, making it illegal to geofence these locations to identify or track individuals engaged in protected health care activities.

Moreover, the bill amends existing laws related to prescription filling and the Confidential Substitute Address Program. It specifies conditions for filling prescriptions for dangerous drugs, requiring pharmacists to document specific information when filling prescriptions without explicit instructions. It also allows for a combined quantity of dangerous drugs not exceeding a ninety-day supply and clarifies that practitioners can indicate "prn" on prescriptions for a twelve-month filling period. The bill expands the Confidential Substitute Address Program to include "protected health care providers" and victims of domestic violence, detailing the application process and emphasizing confidentiality in handling participant records, including strict access controls and staff training requirements.

Statutes affected:
introduced version: 24-14B-2, 24-14B-3, 24-14B-6, 24-14B-7, 24-35-1, 24-35-6, 24A-1-7, 26-1-16, 40-13B-2, 40-13B-3, 40-13B-4, 40-13B-5, 40-13B-7, 40-13B-8
HC substitute: 24-35-4, 24A-1-7, 26-1-16, 40-13B-2, 40-13B-3, 40-13B-4, 40-13B-5, 40-13B-7, 40-13B-8